Letter: Allostatic Load and Adverse Prognosis in Inflammatory Bowel Disease-Need More Evidence. Authors' Reply

被引：0
|
作者：
Zhao, Jianhui [1 ,2 ]
Xue, Erxu [3 ]
Liu, Zhanju [4 ]
Li, Xue [1 ,2 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Big Data Hlth Sci, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Publ Hlth, Sch Med, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Nursing Dept, Sch Med, Hangzhou, Zhejiang, Peoples R China
[4] Tongji Univ, Shanghai Peoples Hosp 10, Ctr Inflammatory Bowel Dis Res, Sch Med,Dept Gastroenterol, Shanghai, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 60卷 / 10期
基金：
中国国家自然科学基金;
关键词：
SURVIVAL ANALYSIS;
D O I：
10.1111/apt.18303
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1485 / 1486
页数：2
相关论文
共 50 条
  • [1] Letter: Allostatic load and adverse prognosis in inflammatory bowel disease-Need more evidence
    Xu, Lingyu
    Guan, Chen
    Zhao, Long
    Xu, Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1483 - 1484
  • [2] Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply
    Zhao, Jianhui
    Xue, Erxu
    Liu, Zhanju
    Li, Xue
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 190 - 191
  • [3] Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease
    Zhao, Jianhui
    Xue, Erxu
    Zhou, Siyun
    Zhang, Meng
    Jiang, Fangyuan
    Wu, Wei
    Liu, Zhanju
    Li, Xue
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (08) : 1062 - 1074
  • [4] Letter: Allostatic load-A potential key in the development of inflammatory bowel disease
    Kharal, Maryam
    Shahbaz, Muhammad Hassan
    Nadeem, Muhammad Salman
    Shahbaz, Sana
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1505 - 1506
  • [5] Letter: diagnostic delay in inflammatory bowel disease-Authors' reply
    Pollok, Richard
    Baillie, Samantha
    Jayasooriya, Nishani
    Blackwell, Jonathan
    Petersen, Irene
    Bottle, Alex
    Saxena, Sonia
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1205 - 1206
  • [6] Letter: pancreatic involvement in inflammatory bowel disease-authors' reply
    Massironi, Sara
    Vigano, Chiara
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) : 371 - 371
  • [7] Letter: dermatological complications with therapy for inflammatory bowel disease authors' reply
    Ghosh, S.
    Moran, G. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (02) : 233 - 234
  • [8] Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' reply
    Chapman, Thomas P.
    Frias Gomes, Catarina
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1621 - 1621
  • [9] Letter: causes of fatigue in inflammatory bowel disease remain uncertain - authors' reply
    Artom, M.
    Czuber-Dochan, W.
    Norton, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) : 763 - 764
  • [10] Letter: screening for adrenal suppression in paediatric inflammatory bowel disease - authors' reply
    Philpott, Hamish
    Dougherty, Michael K.
    Dellon, Evan S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (08) : 885 - 886
12345